WO2009008345A1 - 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 - Google Patents
金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 Download PDFInfo
- Publication number
- WO2009008345A1 WO2009008345A1 PCT/JP2008/062133 JP2008062133W WO2009008345A1 WO 2009008345 A1 WO2009008345 A1 WO 2009008345A1 JP 2008062133 W JP2008062133 W JP 2008062133W WO 2009008345 A1 WO2009008345 A1 WO 2009008345A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metal complex
- complex compound
- active ingredient
- therapeutic composition
- production
- Prior art date
Links
- -1 Metal complex compound Chemical class 0.000 title abstract 9
- 239000004480 active ingredient Substances 0.000 title abstract 3
- 239000012830 cancer therapeutic Substances 0.000 title abstract 3
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 208000037819 metastatic cancer Diseases 0.000 abstract 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2479—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1)
- C07F9/2495—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1) containing the structure P(=X)n-N-P (X = O, S, Se; n = 0, 1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/4028—Esters of poly(thio)phosphonic acids containing no further substituents than -PO3H2 groups in free or esterified form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/4028—Esters of poly(thio)phosphonic acids containing no further substituents than -PO3H2 groups in free or esterified form
- C07F9/4031—Acyclic unsaturated derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/4028—Esters of poly(thio)phosphonic acids containing no further substituents than -PO3H2 groups in free or esterified form
- C07F9/4034—Cycloaliphatic derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/405—Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/667,741 US20110034714A1 (en) | 2007-07-06 | 2008-07-04 | Metal complex compound, cancer therapeutic agent composition containing the metal complex compound as an active ingredient, and intermediate for the metal complex compound |
EP08790864A EP2177525A1 (en) | 2007-07-06 | 2008-07-04 | Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound |
JP2009522605A JPWO2009008345A1 (ja) | 2007-07-06 | 2008-07-04 | 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-179040 | 2007-07-06 | ||
JP2007179040 | 2007-07-06 | ||
JP2008034907 | 2008-02-15 | ||
JP2008-034907 | 2008-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009008345A1 true WO2009008345A1 (ja) | 2009-01-15 |
Family
ID=40228522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/062133 WO2009008345A1 (ja) | 2007-07-06 | 2008-07-04 | 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20110034714A1 (ja) |
EP (1) | EP2177525A1 (ja) |
JP (1) | JPWO2009008345A1 (ja) |
WO (1) | WO2009008345A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010535803A (ja) * | 2007-08-06 | 2010-11-25 | オハイオ ユニバーシティー | ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用 |
JP2014520849A (ja) * | 2011-07-08 | 2014-08-25 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 |
JP2020504140A (ja) * | 2017-01-06 | 2020-02-06 | フォスプラティン・セラピューティクス・エルエルシー | 骨がんまたは血液がんの治療のための治療薬としてのホスファプラチン化合物 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108409795A (zh) | 2010-06-04 | 2018-08-17 | 俄亥俄大学 | 磷铂及其在治疗癌症中的用途 |
US20130236568A1 (en) * | 2011-01-12 | 2013-09-12 | Ohio University | Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
CN114349794B (zh) * | 2021-10-31 | 2023-11-24 | 南京医科大学 | 一种双膦酸铂配合物及其合成方法及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436386B1 (en) | 2000-11-14 | 2002-08-20 | Shearwater Corporation | Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
WO2005000858A2 (en) | 2003-06-27 | 2005-01-06 | Akira Odani | Bisphosphonate complexes |
-
2008
- 2008-07-04 JP JP2009522605A patent/JPWO2009008345A1/ja not_active Withdrawn
- 2008-07-04 US US12/667,741 patent/US20110034714A1/en not_active Abandoned
- 2008-07-04 EP EP08790864A patent/EP2177525A1/en not_active Withdrawn
- 2008-07-04 WO PCT/JP2008/062133 patent/WO2009008345A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436386B1 (en) | 2000-11-14 | 2002-08-20 | Shearwater Corporation | Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
WO2005000858A2 (en) | 2003-06-27 | 2005-01-06 | Akira Odani | Bisphosphonate complexes |
Non-Patent Citations (22)
Title |
---|
CHARLES R. DEGENHARDT; DON C. BURDSALL, J. ORG. CHEM., vol. 51, 1986, pages 3488 - 3490 |
CHU, J. BIOL. CHEM., vol. 269, 1994, pages 787 - 90 |
DOMINIQUE C. STEPINSKI; DEREK W. NELSON; PETER R. ZALUPSKI; ALBERTW. HERLINGER, TETRAHEDRON, vol. 57, 2001, pages 8637 - 8645 |
DONALDSON ET AL., INT. J. CANCER, vol. 57, 1994, pages 847 - 55 |
F.SAAD ET AL., JNCI., vol. 94, 2002, pages 1458 - 1468 |
GANTLA VIDYASAGAR REDDY; ALBERT W. HERLINGER, SYNTHETIC COMMUNICATIONS, vol. 34, no. 5, 2004, pages 331 - 344 |
H.FLEISCH., ANN. MED., vol. 29, 1997, pages 55 - 62 |
HERLINGER A.W. ET AL.: "An investigation of P,P'-di(2-ethylhexyl)methanediphosphonic acid and some of its metal complexes", POLYHEDRON, vol. 16, no. 11, 1997, pages 1843 - 1854, XP008129148 * |
HOWLE ET AL., BIOCHEM. PHARMACOL., vol. 19, 1970, pages 2757 - 62 |
JANE R. HANRAHAN; DAVID W. HUTCHINSON, TETRAHEDRON LETTERS, vol. 34, no. 23, 1993, pages 3767 - 3768 |
KRISHNASWAMY ET AL., MUTATION RES., vol. 293, 1993, pages 161 - 72 |
PANKIEWICZ K.W. ET AL.: "Novel Mycophenolic Adenine Bis(phosphonate) Analogues As Potential Differentiation Agents against Human Leukemia", JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, no. 3, 2002, pages 703 - 712, XP008037228 * |
PHILLIP C. B. PAGE; MICHAEL J. MCKENZIE; JAMES A. GALLANGHER, J.ORG. CHEM, vol. 66, 2001, pages 3704 - 3708 |
PINTO ET AL., PROC. NAT. ACAD. SCI., vol. 82, 1985, pages 4616 - 19 |
POTAPOVA I.A. ET AL.: "Interaction of dNTP, pyrophosphate and their analogs with the dNTP-binding sites of E. coli DNA polymerase I Klenow fragment and human DNA polymerase alpha", FEBS LETTERS, vol. 277, no. 1,2, 1990, pages 194 - 196, XP025607904 * |
ROBERTS ET AL., PROG. NUCL. ACID RES. MOL. BIOL., vol. 22, 1979, pages 71 - 133 |
SALLES ET AL., BIOCHEM. BIOPHYS, RES. COMMUN., vol. 112, 1983, pages 555 - 63 |
SERGIO H. SZAJNMAN; ANDREA MONTALVETTI; YOUHONG WANG, ROBERTODOCAMPO; JUAN B. RODRIGUEZ, BIOORG. MED. CHEM. LETT., vol. 13, 2003, pages 3231 - 3235 |
SERGIO H. SZAJNMAN; ANDREA MONTALVETTI; YOUHONG WANG; JUAN B. RODRIGUEZ, BIOORG. MED. CHEM. LETT., vol. 13, 2003, pages 3231 - 3235 |
SHERMAN ET AL., CHEM. REV., vol. 87, 1987, pages 1153 - 81 |
SORESON ET AL., J. NATI. CANCER INST., vol. 82, 1990, pages 749 - 55 |
WOOD ET AL., J. PHARMACOL. EXP. THER., vol. 302, no. 3, 2002, pages 1055 - 61 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010535803A (ja) * | 2007-08-06 | 2010-11-25 | オハイオ ユニバーシティー | ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用 |
JP2013227218A (ja) * | 2007-08-06 | 2013-11-07 | Ohio Univ | ホスファプラチン、ならびにシスプラチンおよびカルボプラチンに対し耐性を有する癌の治療におけるその使用 |
JP2014520849A (ja) * | 2011-07-08 | 2014-08-25 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 |
JP2020504140A (ja) * | 2017-01-06 | 2020-02-06 | フォスプラティン・セラピューティクス・エルエルシー | 骨がんまたは血液がんの治療のための治療薬としてのホスファプラチン化合物 |
JP7023968B2 (ja) | 2017-01-06 | 2022-02-22 | フォスプラティン・セラピューティクス・インコーポレーテッド | 骨がんまたは血液がんの治療のための治療薬としてのホスファプラチン化合物 |
Also Published As
Publication number | Publication date |
---|---|
EP2177525A1 (en) | 2010-04-21 |
US20110034714A1 (en) | 2011-02-10 |
JPWO2009008345A1 (ja) | 2010-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007024843A3 (en) | Pyrimidinyl-pyrazole inhibitors of aurora kinases | |
UA89123C2 (ru) | Производные пиримидина для лечения абнормального роста клеток | |
TW200833675A (en) | Nicotinamide derivatives | |
UA97351C2 (ru) | Производная кумарина, имеющая противоопухолевую активность | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
TW200612949A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
WO2006067445A3 (en) | Csf-1r kinase inhibitors | |
WO2010026436A3 (en) | 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders | |
MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
TW200607801A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
TW200604175A (en) | Ortho substituted aryl or heteroaryl amide compounds | |
WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
MXPA06013164A (es) | Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal. | |
WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
MX2007013624A (es) | Inhibidores de proteina cinasa. | |
GB0112348D0 (en) | Compounds | |
AU2006325931A8 (en) | Amine compound and use thereof for medical purposes | |
WO2009008345A1 (ja) | 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 | |
WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
MY151072A (en) | Heteroaryl derivative | |
MX2009012125A (es) | Compuestos terapeuticos. | |
WO2008106125A3 (en) | Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08790864 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009522605 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12667741 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008790864 Country of ref document: EP |